Skip to main content
. Author manuscript; available in PMC: 2019 Mar 18.
Published in final edited form as: Vet Comp Oncol. 2016 Oct 25;15(4):1309–1322. doi: 10.1111/vco.12272

Figure 6.

Figure 6.

Tumor cells within hemangiosarcoma metastases demonstrate positive immunolabeling for CCL2. All evaluated cases (n=5) demonstrated strong, positive immunolabeling for CCL2. (A) In all cases, greater than 50-75% of tumor cells within hemangiosarcoma pulmonary metastases demonstrated moderate to strong immunoreactivity for CCL2. 20x magnification. DAB chromogen. Hematoxylin counterstain. (B) Higher magnification image of the same case in (A), which demonstrates the strongly positive, intra-cytoplasmic, peri-nuclear (golgi zone) localization for CCL2 within tumor cells. 50x magnification.